Fri Sep 20 14:00:00 UTC 2024: ## Combined CT and PET Imaging Improves Esophageal Cancer Lymph Node Metastasis Detection

**Isehara, Japan** – A new study published in PLOS ONE reveals a significant improvement in detecting lymph node metastasis in patients with esophageal squamous cell carcinoma using a combination of dual-energy computed tomography (CT) and positron-emission tomography (PET) parameters.

Researchers at Tokai University School of Medicine analyzed data from 27 patients with esophageal cancer, comparing CT and PET measurements of lymph nodes with confirmed pathological results.

The study found that while both dual-energy CT and PET parameters individually showed promise, the combination significantly enhanced diagnostic accuracy. Specifically, iodine concentration (IC) from dual-energy CT and maximum standardized uptake value (SUVmax) from PET proved to be independent predictors of lymph node metastasis.

“This combination of parameters may have diagnostic value for metastatic lymph nodes in patients with esophageal squamous cell carcinoma,” said lead author Dr. Xinyu Sun. “The area under the curve of the combined parameters was 0.884, with 83.3% sensitivity and 86.5% specificity, significantly higher than those of IC alone.”

The study highlights the advantages of dual-energy CT and PET in assessing lymph node metastasis: dual-energy CT provides detailed information on tissue composition, while PET offers insight into metabolic activity. This combined approach allowed researchers to identify crucial indicators of metastasis that might have been missed using either imaging modality alone.

While the study acknowledges limitations due to a relatively small sample size and the focus on surgically resected lymph nodes, it provides valuable information for improving the diagnosis and treatment of esophageal cancer.

“This study provides evidence that dual-energy CT and PET parameters, when used in conjunction, can significantly improve the detection of lymph node metastasis in esophageal squamous cell carcinoma,” said Dr. Sun. “This could lead to more accurate staging, personalized treatment plans, and potentially better outcomes for patients.”

Further research with larger sample sizes and investigations into the role of micrometastasis is needed to validate these findings and refine the use of this combined imaging approach for esophageal cancer diagnosis.

Read More